Cobb PW - Search Results

1

Cobb PW, LeMaistre CF. Cobb PW, et al. Semin Hematol. 1992 Jul;29(3 Suppl 2):6-13. Semin Hematol. 1992. PMID: 1509295 Review.

2

Mixed-lineage acute myeloid leukemia associated with a suprasellar dysgerminoma.

Krywicki R, Bowen K, Anderson L, Garland D, Cobb P, Jenkins T, O'Rourke T. Krywicki R, et al. Am J Clin Oncol. 1995 Feb;18(1):83-6. doi: 10.1097/00000421-199502000-00018. Am J Clin Oncol. 1995. PMID: 7847266

3

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.

Burris HA 3rd, Awada A, Kuhn JG, Eckardt JR, Cobb PW, Rinaldi DA, Fields S, Smith L, Von Hoff DD. Burris HA 3rd, et al. Among authors: cobb pw. Anticancer Drugs. 1994 Aug;5(4):394-402. doi: 10.1097/00001813-199408000-00002. Anticancer Drugs. 1994. PMID: 7949242 Clinical Trial.

4

Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil.

Vukelja SJ, Bonner MW, McCollough M, Cobb PW, Gaule DA, Fanucchi PJ, Keeling JH. Vukelja SJ, et al. Among authors: cobb pw. J Am Acad Dermatol. 1991 Nov;25(5 Pt 2):905-8. doi: 10.1016/0190-9622(91)70280-f. J Am Acad Dermatol. 1991. PMID: 1837033 Review.

5

Activity of DMP 840, a new bis-naphthalimide, on primary human tumor colony-forming units.

Cobb PW, Degen DR, Clark GM, Chen SF, Kuhn JG, Gross JL, Kirshenbaum MR, Sun JH, Burris HA 3rd, Von Hoff DD. Cobb PW, et al. J Natl Cancer Inst. 1994 Oct 5;86(19):1462-5. doi: 10.1093/jnci/86.19.1462. J Natl Cancer Inst. 1994. PMID: 8089865

6

A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon.

Eckardt JR, Campbell E, Burris HA, Weiss GR, Rodriguez GI, Fields SM, Thurman AM, Peacock NW, Cobb P, Rothenberg ML, et al. Eckardt JR, et al. Am J Clin Oncol. 1994 Dec;17(6):498-501. doi: 10.1097/00000421-199412000-00009. Am J Clin Oncol. 1994. PMID: 7977168 Clinical Trial.

7

A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies.

Villalona-Calero MA, Petit T, Kuhn J, Cobb P, Kraynak M, Eckhardt SG, Drengler R, Simmons C, Santabarbara P, Von Hoff DD, Rowinsky EK. Villalona-Calero MA, et al. Clin Cancer Res. 1999 Nov;5(11):3369-78. Clin Cancer Res. 1999. PMID: 10589747 Clinical Trial.

8

Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule.

Cobb PW, Havlin KA, Kuhn JG, Craig JB, Harman GS, Luther JS, Turner JN, Weiss GR, Tweedy DA, Koeller J, et al. Cobb PW, et al. Sel Cancer Ther. 1991 Summer;7(2):85-91. doi: 10.1089/sct.1991.7.85. Sel Cancer Ther. 1991. PMID: 1754731 Clinical Trial.

9

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase.

Kantarjian HM, Larson RA, Guilhot F, O'Brien SG, Mone M, Rudoltz M, Krahnke T, Cortes J, Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Kantarjian HM, et al. Cancer. 2009 Feb 1;115(3):551-60. doi: 10.1002/cncr.24066. Cancer. 2009. PMID: 19117345 Free PMC article.

10

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.

Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y; IRIS (International Randomized Interferon vs STI571) Study Group. Larson RA, et al. Blood. 2008 Apr 15;111(8):4022-8. doi: 10.1182/blood-2007-10-116475. Epub 2008 Feb 6. Blood. 2008. PMID: 18256322 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters